The doctor says protein-based drugs such as Ozempic and Keytruda are where medicine is heading and argues the trial process should be streamlined.
Recap by typeshit. Post by Kashif Pirzada, MD on X.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
The weekly shot reportedly costs about 130,000 won for the first month, roughly half of Mounjaro's lowest dose supply price.
The writer argues GLP-1 buzz risks drowning out the case for treating obesity as a long-term disease with individualized care.
Loading…